Inability to Fully Suppress Sterol Synthesis Rates with Exogenous Sterol in Embryonic and Extraembyronic Fetal Tissues

Overview

Journal Biochim Biophys Acta

Specialties Biochemistry
Biophysics

Date 2007 Oct 24

PMID 17950663

Citations 8

Authors

Lihang Yao

Katie Jenkins

Paul S Horn

M Hayden Lichtenberg

Laura A Woollett

Affiliations

Soon will be listed here.

Abstract

The requirement for cholesterol is greater in developing tissues (fetus, placenta, and yolk sac) as compared to adult tissues. Here, we compared cholesterol-induced suppression of sterol synthesis rates in the adult liver to the fetal liver, fetal body, placenta, and yolk sac of the Golden Syrian hamster. Sterol synthesis rates were suppressed maximally in non-pregnant adult livers when cholesterol concentrations were increased. In contrast, sterol synthesis rates were suppressed only marginally in fetal livers, fetal bodies, placentas, and yolk sacs when cholesterol concentrations were increased. To begin to elucidate the mechanism responsible for the blunted response of sterol synthesis rates in fetal tissues to exogenous cholesterol, the ratio of sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP) to Insig-1 was measured in these same tissues since the ratio of SCAP to the Insigs can impact SREBP processing. The fetal tissues had anywhere from a 2- to 6-fold greater ratio of SCAP to Insig-1 than did the adult liver, suggesting constitutive processing of the SREBPs. As expected, the level of mature, nuclear SREBP-2 was not different in the fetal tissues with different levels of cholesterol whereas it was different in adult livers. These findings indicate that the suppression of sterol synthesis to exogenous sterol is blunted in developing tissues and the lack of response appears to be mediated at least partly through relative levels of Insigs and SCAP.

Citing Articles

Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases.

Kloska A, Wesierska M, Malinowska M, Gabig-Ciminska M, Jakobkiewicz-Banecka J Int J Mol Sci. 2020; 21(17).

PMID: 32854299 PMC: 7504288. DOI: 10.3390/ijms21176113.

Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease.

Dumolt J, Patel M, Rideout T J Dev Orig Health Dis. 2020; 12(2):229-236.

PMID: 32290895 PMC: 7572900. DOI: 10.1017/S2040174420000239.

Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice.

Dumolt J, Ma M, Mathew J, Patel M, Rideout T Am J Physiol Endocrinol Metab. 2019; 317(5):E831-E838.

PMID: 31453710 PMC: 6879864. DOI: 10.1152/ajpendo.00138.2019.

Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta.

Chatuphonprasert W, Jarukamjorn K, Ellinger I Front Pharmacol. 2018; 9:1027.

PMID: 30258364 PMC: 6144938. DOI: 10.3389/fphar.2018.01027.

Multiparity leads to obesity and inflammation in mothers and obesity in male offspring.

Rebholz S, Jones T, Burke K, Jaeschke A, Tso P, DAlessio D Am J Physiol Endocrinol Metab. 2011; 302(4):E449-57.

PMID: 22127227 PMC: 3287352. DOI: 10.1152/ajpendo.00487.2011.

References

Song B, Javitt N, DeBose-Boyd R . Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 2005; 1(3):179-89. DOI: 10.1016/j.cmet.2005.01.001. View

Yoshida S, Wada Y . Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res. 2005; 46(10):2168-74. DOI: 10.1194/jlr.M500096-JLR200. View

Kelley R, Roessler E, Hennekam R, Feldman G, Kosaki K, Jones M . Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?. Am J Med Genet. 1996; 66(4):478-84. DOI: 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q. View

Yabe D, Xia Z, Adams C, Rawson R . Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols. Proc Natl Acad Sci U S A. 2002; 99(26):16672-7. PMC: 139202. DOI: 10.1073/pnas.262669399. View

Turley S, Spady D, Dietschy J . Identification of a metabolic difference accounting for the hyper- and hyporesponder phenotypes of cynomolgus monkey. J Lipid Res. 1997; 38(8):1598-611. View

Yang T, Goldstein J, Brown M . Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP.SREBP exit from endoplasmic reticulum. J Biol Chem. 2000; 275(38):29881-6. DOI: 10.1074/jbc.M005439200. View

Jegathesan J, Liebenthal J, Arnett M, Clancy R, Pierce J . Apoptosis: understanding the new molecular pathway. Medsurg Nurs. 2005; 13(6):371-5. View

Porter J, Young K, Beachy P . Cholesterol modification of hedgehog signaling proteins in animal development. Science. 1996; 274(5285):255-9. DOI: 10.1126/science.274.5285.255. View

Tulenko T, Boeze-Battaglia K, Mason R, Tint G, Steiner R, Connor W . A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J Lipid Res. 2005; 47(1):134-43. DOI: 10.1194/jlr.M500306-JLR200. View

10.

Osborne T . Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem. 2000; 275(42):32379-82. DOI: 10.1074/jbc.R000017200. View

11.

Keller R, Arnold T, Fliesler S . Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J Lipid Res. 2003; 45(2):347-55. PMC: 2851617. DOI: 10.1194/jlr.M300232-JLR200. View

12.

Cooper M, Porter J, Young K, Beachy P . Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 1998; 280(5369):1603-7. DOI: 10.1126/science.280.5369.1603. View

13.

Spady D, Dietschy J . Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest. 1988; 81(2):300-9. PMC: 329571. DOI: 10.1172/JCI113321. View

14.

Horton J, Shimomura I . Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol. 1999; 10(2):143-50. DOI: 10.1097/00041433-199904000-00008. View

15.

Lee J, Song B, DeBose-Boyd R, Ye J . Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J Biol Chem. 2006; 281(51):39308-15. DOI: 10.1074/jbc.M608999200. View

16.

Sever N, Yang T, Brown M, Goldstein J, DeBose-Boyd R . Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell. 2003; 11(1):25-33. DOI: 10.1016/s1097-2765(02)00822-5. View

17.

Riddle T, Kuhel D, Woollett L, Fichtenbaum C, Hui D . HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. J Biol Chem. 2001; 276(40):37514-9. DOI: 10.1074/jbc.M104557200. View

18.

Nakanishi M, Goldstein J, Brown M . Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J Biol Chem. 1988; 263(18):8929-37. View

19.

Song B, Sever N, DeBose-Boyd R . Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell. 2005; 19(6):829-40. DOI: 10.1016/j.molcel.2005.08.009. View

20.

Porter F . Malformation syndromes due to inborn errors of cholesterol synthesis. J Clin Invest. 2002; 110(6):715-24. PMC: 151134. DOI: 10.1172/JCI16386. View